IDEXX LABORATORIES, INC.
IDXX US45168D1046
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 34% | -35% | 37% | -25% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Szostak M Anne |
647.33 USD |
2,187 Sold |
1,415,700 USD |
22/08/2025 | 22/08/2025 |
| Erickson Michael G EX VP |
649.99 USD |
318 Sold |
206,697 USD |
12/08/2025 | 12/08/2025 |
| Erickson Michael G EX VP |
649.85 USD |
88 Sold |
57,117 USD |
12/08/2025 | 12/08/2025 |
| Hunt Nimrata EX VP |
656.53 USD |
1,200 Sold |
787,840 USD |
11/08/2025 | 11/08/2025 |
| Underberg Sharon E. EX VP |
651.60 USD |
5,450 Sold |
3,551,220 USD |
08/08/2025 | 08/08/2025 |
| Mazelsky Jonathan Jay CEO |
632.56 USD |
3,000 Sold |
1,897,689 USD |
06/08/2025 | 06/08/2025 |
| Lane Michael EX VP |
628.89 USD |
300 Sold |
188,666 USD |
06/08/2025 | 06/08/2025 |
| Lane Michael EX VP |
627.56 USD |
5,631 Sold |
3,533,810 USD |
06/08/2025 | 06/08/2025 |
| Mazelsky Jonathan Jay CEO |
631.61 USD |
7,299 Sold |
4,610,096 USD |
06/08/2025 | 06/08/2025 |
| Hunt Nimrata EX VP |
629.87 USD |
3,018 Sold |
1,900,933 USD |
06/08/2025 | 06/08/2025 |